Mass Spectrometry 3 Flashcards

1
Q

MS Interpretation

A
  1. General inspection
    - Identify base peak (can be (quasi-)molecular ion!)
    - Lot of fragmentation or limited number of stable ions?
  2. Identify highest m/z (take isotopes into account!)
    - Are you certain this is M+●?
    - If so then mass odd/even → nr. of N
  3. Are there “A + 2” elements?
  4. Use above & find all potential molecular formulae (may help to use 12C/13C calculation)
  5. Check if formulae can explain OE+.
  6. Derive structure using all information incl.
    - Tables (peaks and losses) - Basic principles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common Fragmentation Patterns

A

• Electronegative atom tends to carry + charge
• α-cleavage (bond in α position to site of ionisation):
Fission of bond at atom adjacent to charged atom

– Homolytic
– Heterolytic
• Protontransfer
• Ring structure fragmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

α Cleavage: EtOH

A
• Homolytic: 1 electron remains on each atom
• O electronegative
• 2 electrons:
1 to radical
1 to C=O
• Loss of
largest radical
favoured
• + on electroneg atom

• Heterolytic
• Minor here
• Homolytic favoured
if hetero atoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Homolytic cleavages

A
  • Homolytic α-cleavages:
  • OH
  • C=O
  • C-O-C
  • C-NH2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Self-test

A
• Butan-2-ol. 
• Indicate the
– type(s) of cleavage 
– fragments lost
for the major ions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Common losses for EI

A

H radical - often a major ion in amines, alcohols and aldehydes
CH3 radical - most readily lost from quaternary C
H2O - readily lost from secondary or tertiary alcohols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ring structures: Cyclohexanol

A

Molecular rearrangement prior to fragmentation more likely if ring
Base peak: C3H5O+

  1. O+•
  2. Homolytic cleavage 3. H-transfer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diels-Alder fragmentation

A
  • Can occur with ring systems

• Example: Limonene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug molecules

A
  • Abundant molecular ion (codeine)
  • Homolytic α-cleavage (bupivacaine)
  • Isotope peaks (chloroquinone)
  • Tropylium ion (L-dopa)
  • McLafferty rearrangement (apronal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Codeine

A
  • Ring -> fragmentation complex
    • 229 closely related to codeine structure
    – Does require re- arrangement of ring
    • Drugs with extensive ring structures tend to have large molecular ion peaks if…
    • No side chains
    • Side chains without hetero atoms to direct cleavage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bupivacaine

A
• No obvious molecular ion
• Homolytic α-cleavage
• Directed by N in ring
• m/z 140 dominates spectrum
– Note that even mass rule does not apply to fragments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Isotope peaks: Chloroquinone

A
  • (A):EI
  • α-Homo cleavage
  • Adjacent N in chain
  • (B):NICI (NI = neg ion CI = chem. ionisation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tropylium ion: L-dopa

A
• Benzyl group
• Very stable cation
• Other processes may
compete
• Here: homolytic cleavage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

McLafferty rearrangement

A
• -COOH, Esters
• Ketones
• Amides
• side chain ≥ 3C-atoms
• Unusual for drugs – α-cleavage
– Long chain lipid (such as fatty acid esters)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

More than just MS…

A
• GC-MS
– Ionisation techniques:
• EI / PICI / NICI
– Applications:
• Impurity profiling 
• LC-MS
• Tandem-MS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Enhancing the “molecular” ion

• Electrospray Ionisation (ESI):

A

– Add or remove H+ (using acid-base chemistry)
– Add Na+, K+ (naturally in solution / dopant) – adducts
– Crucial: also better to get large (bio-) molecules into vapour and couples well with LC

17
Q

Enhancing the “molecular” ion

• Chemical Ionisation (CI): PICI / NICI

A

– Target functionality with choice of reagents
– Tweak energy to get desired level of fragmentation
– PICI: adducts; NICI: M-

18
Q

Enhancing the “molecular” ion

• Laser-ablation (MALDI)

A

– (Deposit sample onto solid substrate)

– Add matrix

19
Q

Positive Ion Chemical Ionisation

A
  • PICI

* CH4

20
Q

Negative Ion “Chemical Ionisation”

A
  • NICI requires electron-capturing compound to analyse
    • Generate low energy electrons by collisions with reagent gas: < 10 eV
    – Resonance electron capture: AB-
    – Dissociative electron capture: A- + B
    • Psoralen
21
Q

GC-MS: Impurity profiling

A
  • FDA: identify if > 0.1%
  • Propanolol
  • Commercial sample
22
Q

Collision-Induced Dissociation (CID)

A

-EI = hard ionisation -> extensive (too much?) fragmentation
-PICI, NICI much “softer”
-ESI often used in combination with LC
– Very soft

-clear molecular ion, but not much fragmentation
Need fragmentation to solve molecular structure!

CID in tandem-MS (or MS/MS or MS-MS or MSn)

  1. Often using 3 quadrupole mass filters in sequence
  2. Molecular ion selected (Q1)
  3. fragmented using Ar-gas in collision cell (Q2)
  4. Separated (Q3)
23
Q

Tandem-MS (MS/MS)

A
  • Lidocaine
  • ESI
  • Ketamine
24
Q

Example: Kanamycin

A
  • Extremely polar
  • 4 basic centres
  • ESI: Unfragmented
  • CID of m/z 485
25
ESI & Multiple Charge States
• Highest charged state ~ # basic functionalities (not precise, often works...) • Extends mass range for same analyser: m/z • Molecular weight ↔ nr. of “molecular ion” peaks - calculate the molecular weight with ease & precision
26
MS of Proteins
-Most instruments: m/z < 3000 Da -Proteins > 3000 Da -need multiple charges! • n = charge on MB (≈ z) • MA, MB adjacent ions • Mass: MA>MB
27
MS of Proteins | mass =
mass = (m/z) x z
28
MS of Proteins | n =
MA - 1/ MA- MB
29
Applications of LC-MS in Pharmacy
- Quality control: Determination of impurities • Use in drug discovery • Drug (formulation) degradation • Profiling impurities & degradants
30
QC: Impurities
* insulin-like growth factor * ESI-MS * Protein mass * Identify impurities
31
MS in drug discovery
``` • Leuenkephalin – opioid – peptide – ESI – m/z 556 ```
32
LC-MS: Degradant of famotidine
* Effect of stress conditions in pack | * LC-MS
33
• Famotidine
* Famotidine MS-MS | * Same for degradant